Skip to main content
Legendary Crypto Analyst Names 3 Coins to Buy Instead of Coinbase
Matt McCall’s crypto portfolio has delivered multiple 1,000% winners in just months…

Now he’s naming 3 tokens he believes folks should own instead of the Coinbase stock in a free report.
Click here to get your copy today.
Stephane  Bancel, insider at Moderna

Stephane Bancel Insider Information

CEO of Moderna

Stéphane Bancel is a French billionaire businessman and the CEO of Moderna Therapeutics, a clinical stage biotechnology company. 

Bancel joined Moderna’s board of directors in 2011, the same year he was brought on as CEO. The biotech company focuses on the discovery and development of messenger RNA therapeutics and vaccines for infectious, immuno-oncology and cardiovascular diseases. 

With Bancel at the helm during the COVID-19 global pandemic, Moderna was one of the first two vaccine developers to receive authorization in the United States. Moderna’s stock price rose in response to the success of the world’s first mRNA vaccine, making Bancel’s stake in the company worth over $1 billion. 

Prior to Moderna, Bancel was the CEO of French diagnostics company, bioMérieux, from 2007 to 2011. While leading the company, he accelerated bioMérieux’s sales growth rate by pivoting to high-value biomarkers, as well as nearly doubling its market capitalization despite the financial crisis.

He gained experience in the pharmaceutical industry through roles at Eli Lilly including managing director, Belgium and executive director, global manufacturing strategy and supply chain. 

Bancel was elected one of the World Economic Forum’s Young Global Leaders in 2009, Best CEO for Investor Relations in France in 2009, and #1 CEO in the biotechnology sector according to the 2011 Thomson Reuters Pan European EXTEL Study.

Bancel sits on the boards of Qiagen N.V. and Indigo, and he is a venture partner at Flagship Pioneering as well as a trustee for Boston’s Museum of Science. He earned his master of engineering degree at École Centrale Paris, his M.S. in chemical engineering at the University of Minnesota, and his M.B.A. at Harvard Business School.

What is Stephane Bancel's net worth?

The estimated net worth of Stephane Bancel is at least $1.03 billion as of April 28th, 2021. Mr. Bancel owns 6,336,868 shares of Moderna stock worth more than $1,033,860,014 as of May 8th. This net worth evaluation does not reflect any other assets that Mr. Bancel may own. Additionally, Mr. Bancel receives an annual salary of $3,860,000.00 as CEO at Moderna.

How old is Stephane Bancel?

Mr. Bancel is currently 48 years old. There are 6 older executives and no younger executives at Moderna.

What is Stephane Bancel's salary?

As the CEO of Moderna, Inc., Mr. Bancel earns $3,860,000.00 per year.

How do I contact Stephane Bancel?

The corporate mailing address for Mr. Bancel and other Moderna executives is 200 TECHNOLOGY SQUARE, CAMBRIDGE MA, 02139. Moderna can also be reached via phone at 617-714-6500 and via email at [email protected]

Has Stephane Bancel been buying or selling shares of Moderna?

Within the last three months, Stephane Bancel has sold $12,378,405.00 in shares of Moderna stock. Most recently, Stephane Bancel sold 9,000 shares of the business's stock in a transaction on Wednesday, April 28th. The shares were sold at an average price of $182.32, for a transaction totalling $1,640,880.00. Following the completion of the sale, the chief executive officer now directly owns 6,336,868 shares of the company's stock, valued at $1,155,337,773.76.

Are insiders buying or selling shares of Moderna?

During the last year, insiders at the sold shares 196 times. They sold a total of 9,251,534 shares worth mmore than $1,100,545,885.33. The most recent insider tranaction occured on May, 06th when Lori M Henderson General Counsel bought 6,600 shares worth more than $975,612.00. Insiders at Moderna own 29.2 % of the company.

Information on this page was last updated on 5/6/2021.

Stephane Bancel Insider Trading History at Moderna

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/28/2021Sell9,000$182.32$1,640,880.006,336,868View SEC Filing Icon  
4/23/2021Sell11,046$173.21$1,913,277.666,345,868View SEC Filing Icon  
4/21/2021Sell9,000$158.60$1,427,400.006,347,868View SEC Filing Icon  
4/16/2021Sell11,046$166.44$1,838,496.246,356,868View SEC Filing Icon  
4/14/2021Sell9,000$153.75$1,383,750.006,358,868View SEC Filing Icon  
4/9/2021Sell11,046$140.91$1,556,491.866,367,868View SEC Filing Icon  
4/7/2021Sell9,000$131.63$1,184,670.006,369,868View SEC Filing Icon  
4/5/2021Sell11,046$129.77$1,433,439.426,378,868View SEC Filing Icon  
3/31/2021Sell9,000$121.10$1,089,900.006,380,868View SEC Filing Icon  
3/26/2021Sell11,046$132.76$1,466,466.966,389,868View SEC Filing Icon  
3/24/2021Sell9,000$137.07$1,233,630.006,391,868View SEC Filing Icon  
3/18/2021Sell19,000$146.94$2,791,860.006,402,868View SEC Filing Icon  
3/12/2021Sell11,046$135.73$1,499,273.586,411,868View SEC Filing Icon  
3/10/2021Sell9,000$133.24$1,199,160.006,413,868View SEC Filing Icon  
3/5/2021Sell11,046$128.18$1,415,876.286,422,868View SEC Filing Icon  
2/17/2021Sell9,000$174.28$1,568,520.006,444,868View SEC Filing Icon  
2/12/2021Sell11,046$181.98$2,010,151.086,453,868View SEC Filing Icon  
2/10/2021Sell9,000$182.74$1,644,660.006,454,868View SEC Filing Icon  
2/5/2021Sell11,046$174.61$1,928,742.066,463,868View SEC Filing Icon  
2/3/2021Sell9,000$156.51$1,408,590.006,464,868View SEC Filing Icon  
1/29/2021Sell11,046$173.25$1,913,719.506,473,868View SEC Filing Icon  
1/27/2021Sell9,000$151.27$1,361,430.006,474,868View SEC Filing Icon  
1/22/2021Sell11,046$131.81$1,455,973.266,483,868View SEC Filing Icon  
1/20/2021Sell9,000$124.51$1,120,590.006,484,868View SEC Filing Icon  
1/14/2021Sell20,000$117.08$2,341,600.006,494,868View SEC Filing Icon  
1/8/2021Sell11,046$114.02$1,259,464.926,503,868View SEC Filing Icon  
12/30/2020Sell9,000$118.27$1,064,430.006,514,868View SEC Filing Icon  
12/28/2020Sell11,046$116.44$1,286,196.246,523,868View SEC Filing Icon  
12/23/2020Sell9,000$120.00$1,080,000.006,524,868View SEC Filing Icon  
12/21/2020Sell4,729$141.12$667,356.486,533,868View SEC Filing Icon  
12/18/2020Sell11,046$139.60$1,542,021.606,533,868View SEC Filing Icon  
12/16/2020Sell9,000$137.51$1,237,590.006,534,868View SEC Filing Icon  
12/11/2020Sell11,046$159.18$1,758,302.286,543,868View SEC Filing Icon  
12/9/2020Sell9,000$170.00$1,530,000.006,544,868View SEC Filing Icon  
12/4/2020Sell21,046$148.11$3,117,123.066,553,868View SEC Filing Icon  
12/1/2020Sell3,929$178.00$699,362.006,554,868View SEC Filing Icon  
11/27/2020Sell21,046$119.23$2,509,314.586,563,868View SEC Filing Icon  
11/25/2020Sell9,000$99.20$892,800.006,564,868View SEC Filing Icon  
11/20/2020Sell17,514$95.10$1,665,581.406,573,868View SEC Filing Icon  
10/30/2020Sell11,046$68.36$755,104.566,603,868View SEC Filing Icon  
10/28/2020Sell9,000$68.75$618,750.006,604,868View SEC Filing Icon  
10/22/2020Sell10,000$68.58$685,800.006,614,868View SEC Filing Icon  
10/20/2020Sell8,455$72.05$609,182.756,614,868View SEC Filing Icon  
10/16/2020Sell11,046$75.02$828,670.926,623,868View SEC Filing Icon  
10/14/2020Sell9,000$79.81$718,290.006,624,868View SEC Filing Icon  
10/8/2020Sell19,000$72.42$1,375,980.006,634,868View SEC Filing Icon  
10/2/2020Sell11,046$70.64$780,289.446,643,868View SEC Filing Icon  
9/30/2020Sell9,000$72.72$654,480.006,644,868View SEC Filing Icon  
9/24/2020Sell19,000$66.68$1,266,920.006,654,868View SEC Filing Icon  
9/21/2020Sell8,587$68.56$588,724.726,663,868View SEC Filing Icon  
9/18/2020Sell11,046$67.71$747,924.666,663,868View SEC Filing Icon  
9/16/2020Sell9,000$67.69$609,210.006,664,868View SEC Filing Icon  
9/11/2020Sell11,046$58.42$645,307.326,673,868View SEC Filing Icon  
9/4/2020Sell11,046$61.87$683,416.026,683,868View SEC Filing Icon  
8/26/2020Sell9,000$67.45$607,050.006,694,868View SEC Filing Icon  
8/20/2020Sell27,824$67.46$1,877,007.046,703,868View SEC Filing Icon  
8/13/2020Sell19,000$72.22$1,372,180.006,663,858View SEC Filing Icon  
8/5/2020Sell9,000$77.49$697,410.006,674,858View SEC Filing Icon  
7/29/2020Sell9,000$82.00$738,000.006,684,858View SEC Filing Icon  
7/24/2020Sell11,046$71.56$790,451.766,693,858View SEC Filing Icon  
7/22/2020Sell9,000$79.61$716,490.006,694,858View SEC Filing Icon  
7/20/2020Sell6,326$83.53$528,410.786,703,858View SEC Filing Icon  
7/16/2020Sell19,000$83.92$1,594,480.006,704,858View SEC Filing Icon  
7/9/2020Sell10,000$62.04$620,400.006,713,858View SEC Filing Icon  
7/6/2020Sell11,046$59.53$657,568.386,714,858View SEC Filing Icon  
7/1/2020Sell9,000$62.92$566,280.006,715,858View SEC Filing Icon  
6/26/2020Sell11,046$60.65$669,939.906,724,858View SEC Filing Icon  
6/24/2020Sell9,000$63.25$569,250.006,725,858View SEC Filing Icon  
6/22/2020Sell4,521$65.92$298,024.326,734,858View SEC Filing Icon  
6/19/2020Sell11,046$64.61$713,682.066,734,858View SEC Filing Icon  
6/10/2020Sell3,435$58.80$201,978.006,734,858View SEC Filing Icon  
6/5/2020Sell11,046$57.85$639,011.106,734,858View SEC Filing Icon  
6/1/2020Sell4,878$62.67$305,704.266,729,980View SEC Filing Icon  
5/29/2020Sell11,046$58.02$640,888.926,729,980View SEC Filing Icon  
5/20/2020Sell4,186$70.00$293,020.006,734,858View SEC Filing Icon  
5/11/2020Sell3,376$59.57$201,108.326,685,053View SEC Filing Icon  
5/8/2020Sell11,046$56.53$624,430.386,685,053View SEC Filing Icon  
5/1/2020Sell4,349$48.70$211,796.306,688,429View SEC Filing Icon  
4/24/2020Sell11,046$47.15$520,818.906,692,778View SEC Filing Icon  
4/20/2020Sell4,269$45.00$192,105.006,692,778View SEC Filing Icon  
4/17/2020Sell11,046$46.35$511,982.106,692,778View SEC Filing Icon  
4/13/2020Sell3,139$32.00$100,448.006,699,983View SEC Filing Icon  
4/3/2020Sell11,046$32.81$362,419.266,703,122View SEC Filing Icon  
4/1/2020Sell3,339$30.05$100,336.956,703,122View SEC Filing Icon  
3/27/2020Sell11,046$28.37$313,375.026,706,461View SEC Filing Icon  
3/20/2020Sell3,537$29.13$103,032.816,706,461View SEC Filing Icon  
3/13/2020Sell11,046$21.17$233,843.826,709,998View SEC Filing Icon  
2/14/2020Sell11,046$19.02$210,094.926,727,934View SEC Filing Icon  
2/10/2020Sell4,303$23.50$101,120.506,737,237View SEC Filing Icon  
2/7/2020Sell4,876$23.00$112,148.006,737,237View SEC Filing Icon  
1/31/2020Sell11,046$20.43$225,669.786,742,113View SEC Filing Icon  
1/24/2020Sell11,046$21.22$234,396.126,742,113View SEC Filing Icon  
1/21/2020Sell4,850$20.79$100,831.506,757,511View SEC Filing Icon  
1/17/2020Sell11,046$20.96$231,524.166,757,511View SEC Filing Icon  
1/10/2020Sell16,482$20.24$333,595.686,762,500View SEC Filing Icon  
1/2/2020Sell5,114$19.57$100,080.986,762,500View SEC Filing Icon  
12/20/2019Sell11,046$19.69$217,495.746,762,500View SEC Filing Icon  
12/13/2019Sell11,046$18.53$204,682.386,762,500View SEC Filing Icon  
12/6/2019Sell11,046$20.01$221,030.466,720,368View SEC Filing Icon  
11/29/2019Sell11,046$20.54$226,884.846,720,368View SEC Filing Icon  
11/22/2019Sell11,046$20.48$226,222.086,720,368View SEC Filing Icon  
See Full Table

Stephane Bancel Buying and Selling Activity at Moderna

Moderna Company Overview

Moderna logo
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, the Biomedical Advanced Research and Development Authority, the Defense Advanced Research Projects Agency, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the Coalition for Epidemic Preparedness Innovations, and Bill & Melinda Gates Foundation. Moderna, Inc. also has collaborations with Lonza Ltd. for the manufacture of COVID-19 vaccine; and Catalent Inc., Laboratorios Farmacéuticos Rovi, S.A., Recipharm, and Lonza Group for fill-finish manufacturing of its COVID-19 vaccine candidate. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Read More

Overview Details

Today's Range

Now: $163.15

50 Day Range

MA: $152.15

2 Week Range

Now: $163.15


11,952,612 shs

Average Volume

12,035,364 shs

Market Capitalization

$65.35 billion

P/E Ratio


Dividend Yield



Gain the Knowledge You Need to Successfully Trade Futures Markets
Our Technical Analysis Guide will give you the insight into today’s fast-moving markets. It’s designed to give you a head start in learning the basics of various TA tools and techniques.
Download Your Complimentary Technical Analysis Guide TODAY!